People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Invitae Corp | — | Biotechnology | Series C | $203.1M | $2.1B | 2010 |
| Garuda Therapeutics, Inc. | — | Biotechnology | Series C | $158.0M | $379.8M | 2024 |
| Eidos Therapeutics, Inc. | — | Biotechnology | Series B | $26.0M | $1.0B | 2018 |
Eric Aguiar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric Aguiar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| Hoyoung Huh | 1 | 7 |
| Rajeev Shah | 1 | 4 |
| Raymond Kelleher | 1 | 4 |
| Randal Scott | 1 | 4 |
| Steve Liapis | 1 | 3 |
| Neil Kumar | 1 | 3 |
| CHRISTINE GORJANC | 1 | 2 |
| David Kirske | 1 | 2 |
| Adam Craig | 1 | 2 |
| Richard Tompane | 1 | 2 |
| Shaan I Gandhi | 1 | 2 |
| Anya Schiess | 1 | 2 |
| Christine Siu | 1 | 2 |
| Chitra Nayak | 1 | 1 |
| Lee Bendekgey | 1 | 1 |
| JONATHAN FOX | 1 | 1 |
| UMA SINHA | 1 | 1 |
| Sean George | 1 | 1 |
| Michele Cargill | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.